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Abstract: Choroidal dystrophies comprise a group of chorioretinal degenerations. However, the
different findings observed among these patients make it difficult to establish a correct clinical
diagnosis. The objective of this study was to characterize new clinical findings by optical coherence
tomography (OCT) and optical coherence tomography angiography (OCTA) in these patients. Four
family members with a PRPH2 gene mutation (p.Arg195Leu) were included. OCT was performed at
the macula, and the thickness of the outer and inner retina, total retina, and choroid was measured.
The features of the vascular network were analyzed by OCTA. Patients showed a decreased outer
nuclear layer in the avascular area compared with the controls. Two patients presented greater
foveal and parafoveal degeneration of the outer retina, whereas the most degenerated area in the
rest was the perifovea. Disruption of the third outer band at the foveola is one of the first-altered
outer bands. Slow blood flow areas or capillary dropout were main signs in the deep capillary
plexus. Microaneurysms were frequently observed in less degenerated retinas. Vascular loops and
intraretinal microvascular abnormalities (IRMAs) were present in the superficial plexus. Extensive
degeneration of the choriocapillaris was detected. Phenotypic differences were found between
patients: two showed central areolar choroidal dystrophy and the rest had extensive chorioretinal
atrophy. These signs observed in OCT and OCTA can help to more appropriately define the clinical
disease in patients with choroidal dystrophies.
Keywords: capillary dropout; choroidal dystrophies; microaneurysms; optical coherence tomogra-
phy; optical coherence tomography angiography; outer hyperreflective bands; vascular loops
1. Introduction
Choroidal dystrophies are known as ocular diseases that involve a degenerative pro-
cess in the choroid vessels. However, mutations in the retinal pigment epithelium (RPE) [1]
or in the photoreceptors are what lead to choroidal disorders. Among choroidal dystro-
phies, central areolar choroidal dystrophy (CACD), peripapillary choroidal dystrophy,
and diffuse choroidal dystrophy [2], which is also called extensive chorioretinal atrophy
(ECA), have been described. CACD is an inherited retinal dystrophy with a progressive
degeneration of the macula, starting from middle age [3]. Classically, it was characterized
by atrophy of the RPE and choriocapillaris, followed by a decrease in macular photore-
ceptors [4]. Consequently, this degeneration causes a gradual loss in visual acuity (VA)
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and a color perception deficiency between the second and fourth decades of life [5,6]. Four
clinical stages are described for this pathology, ending with severe functional visual loss [5].
In autosomal-dominant CACD, the most frequent cause is PRPH2 gene mutations [7]. The
PRPH2 gene encodes the PRPH2 protein, a structural glycoprotein expressed in rods and
cones, which is involved in the formation and maintenance of the outer segment (OS)
discs [8]. Thus, mutations in this gene result in the first degeneration of photoreceptors [9].
Mutations in the PRPH2 gene present not only large genetic heterogeneity but also
marked phenotypic heterogeneity. Specific PRPH2 gene mutations can cause different eye
disorders among affected members of the same family [10,11]. Specifically, the c.584G > T,
p.Arg195Leu mutation in the PRPH2 gene has only been described in three families with
CACD from Japan, Germany, and Spain [12–15]. The German family showed significant
variability in the family phenotype with age [13]. Here, we describe new clinical findings
using optical coherence tomography (OCT) and OCT angiography (OCTA) in four members
from the Spanish family who showed phenotypic variability. The use of both techniques
improved the capacity to differentiate among all clinical signs, allowing for classification of
these patients with CACD or ECA.
2. Materials and Methods
2.1. Study Design and Initial Diagnosis
This was a cross-sectional study that included 4 members of a Spanish family with
a mutation in the PRPH2 gene (c.584G > T, p.Arg195Leu). The control group included
6 subjects (66.6% men, n = 4), with a mean age of 44± 5 years. The spherical refractive error
of this group was between −1.5 and +2.0 diopters (D), cylinder was less than 1.0 D, and
they had no previous ocular or systemic pathologies. Informed consent was obtained from
each participant before performing the tests. The tenets of the Declaration of Helsinki and
its subsequent amendments were followed, and the Ethics Committee on Human Research
of the University of Alicante approved the study. OCT and OCTA images (Spectralis OCT,
6.9.4.0. version, Heidelberg Engineering Inc., Franklin, USA) were collected between June
and December 2019 at the University of Alicante (Spain).
The medical history of each patient was gathered from when their visual symptoms
began to present. Patient demographic data, age at symptom onset, best-corrected visual
acuity (BCVA), Farnsworth Munsell D-15 test, and available visual field were assessed.
Visual fields analyzed were performed with a standard automated perimetry, following
SITA-Fast or SITA-Standard strategy (24-2 program and umbral test). Automated perimetry
of visual field 10-2 (SITA-Fast or SITA-Standard strategy) results were discarded due to
the low reliability of the test. Full field electroretinogram (ERG) recordings were also
analyzed according to the International Society for Clinical Electrophysiology of Vision
protocols [16].
Initial clinical diagnosis of these patients varied based on their genetic test, elec-
troretinogram, and other functional tests such as visual evoked potential, visual fields, and
fundus eye exams. Most of them were classified with retinal dystrophy or an atypical form
of retinitis pigmentosa. Lastly, choroidal dystrophy was defined in at least 2 of them.
2.2. OCT and OCTA
All images were captured using Spectralis SD-OCT and an angiography module (ver-
sion 6.9.4.0, Heidelberg Engineering Inc., Franklin, USA). Images were acquired under
mesopic light conditions without pupillary dilation. A high-resolution (HR) horizontal
profile at the foveola and a dense scan at the macula were obtained. Superficial vascular
plexus (SVP), intermediate capillary plexus (ICP), deep capillary plexus (DCP), choriocapil-
laris, and choroid images were collected from OCTA images acquired in the macular area.
The automated segmentation was corrected manually due to segmentation errors in OCT
and OCTA images. Qualitative and quantitative (Figure S1) analyses with ImageJ 1.52n
and Angio-tool software (0.6a version, National Cancer Institute, Bethesda, MD, USA [17])
were performed.
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3. Results
3.1. Pedigree of the Spanish Family with the PRPH2 Gene Mutation
Mutation in the PRPH2 gene (c.584G > T, p.Arg195Leu) was confirmed in these four
family members. Due to the autosomal dominant inheritance pattern of the disease, other
family members are also affected. The entire pedigree was constructed up to eleven genera-
tions ago, finding the first affected around 1750 (Figure 1 only shows up to nine generations).
All subsequently affected members descended from this common ancestor (Figure 1A–E).
3.2. Clinical Findings and Evolution of the Disease
The study included four patients with a peripherin mutation (VII.1, VIII.31, VII.94,
and VII.118), aged between 42 and 57 years old, and six control subjects. At the first
ophthalmological examination, patients VIII.31, VII.118, and VII.1 had a similar VA in the
worst eye (20/50 to 20/40). However, the decrease in VA during the progression of the
disease varied considerably amongst them. Focusing on the eye with the BCVA during
the follow-up period, VIII.31 and VII.1 showed a mean decrease in VA of 42.5% over
6.5 years, whereas VII.94′s VA only decreased by 22.5% over 14 years. Visual field indexes
displayed that VII.94 had a marked central scotoma, whereas VII.118 and VII.1 presented
wider-spread degeneration extending to the mid-periphery (Table 1). The results obtained
by ERG showed alterations in retinal function, mainly in the photopic response (Table 1).
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Abbreviations: VA—visual acuity; RE—right eye; LE—left eye; ERG—electroretinogram.
Considering previous structural and functional eye examinations, VIII.31 and VII.94
presented atrophic changes restricted to the macular area that started in middle age. VII.118
and VII.1 showed large atrophic retinal areas involving the macula and mid-periphery, a
large central scotoma in the visual field, and an important impairment of the photopic and
scotopic ERGs. The most recent infrared (IR) fundus images from these patients are shown
in Figure S2.
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Figure 1. Entire pedigree of the Spanish family from 1750 to present. (A) Family members affected are indicated by black-filled shapes: 119 relatives were found to have retinal problems or
blindness, of which 43.47% were women. A total of 60 of them are still alive and it is suspected that 60 more people in this family may also be affected. Most of these family members
reside in the center of Cantabria, a province in Northern Spain. The 4 study family members within this pedigree are situated using red squares. (B–E) Pedigrees of the 4 study subjects.
These subjects belong to different branches, though two of them are more closely related since they share a common descendant in the IV generation. A total of 3 patients (VII.1, VII.94, and
VII.118) belong to the VII generation and the other (VIII.31) to the VIII generation. The autosomal dominant inheritance pattern can be clearly observed.
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3.3. Features of OCT in CACD Patients: Macular Study and Retinal Tomography
Three-dimensional reconstructions of OCT images showed that VIII.31 had a retinal
topographic pattern similar to a healthy retina (Figure S3A) whereas VII.94 showed a higher
atrophy of the central retina (Figure S3B), and VII.118 (Figure S3C) had a better-preserved
central area surrounded by atrophy in the mid-periphery area. OCT images at the foveola
revealed foveal cavitation or optical gap in VIII.31 (Figure 2A). Quantitatively, all patients
showed a marked decrease in total retinal thickness in the foveal avascular zone (FAZ)
compared with the control group (Table 2); this reduction was greater in patients with
lower VA.
Farnsworth Munsell D-15 test results demonstrated a blue-yellow color vision defect
(tritanopic defect) in VIII.31 and VII.94, and color blindness in VII.118 and VII.1.
Figure 2. IR images (left) and OCT line scan at the foveola (right) in study patients. Right-side insets
of all images show different signs in high magnification. (A) The retinal structure of patient VIII.31 is
maintained, although a general thinning exists along the fovea, mainly on the temporal side. First
(red arrowhead), second (yellow arrowhead), and fourth (blue arrowhead) outer retinal bands are
preserved at some areas and some hyperreflective loci, which may be related to the third band (red
arrows). (B) Patient VII.94 presented almost complete degeneration along the retina, specifically at
the fovea, and outer tubulations can be observed (purple arrowhead). Part of the outer nuclear layer
remained on the most temporal side. (C) Patient VII.118 showed a nasal and temporal reduction in
thickness. Some outer retinal bands were observed at the fovea (red, yellow, and blue arrowheads),
and outer tubulations related to this degenerative process can be also seen on the temporal side
(purple arrowheads). (D) Patient VII.1 exhibited a marked reduction in the outer nuclear layer and
only the first outer band is shown at the fovea (red arrowhead). Various outer tubulations were
presented (purple arrowheads). Scale A–D: 200x 200 um. Images of contralateral eye presented a
similar degeneration pattern, though are not shown. Red arrowhead, first outer retinal band; yellow
arrowhead, second band; blue arrowhead, fourth band; red arrow, hyperreflective loci from band 3;
purple arrowheads, outer tubulations.
Diagnostics 2021, 11, 777 6 of 15
Table 2. Thickness in total, outer, and inner retina, and choroid in optical coherence tomography (OCT).
Patients
Total Retinal Thickness (µm) Outer Retina (µm) Inner Retina (µm) Choroid (µm)
Measurements at FAZ
From FAZ limits
(500 µm) to 1.2 mm
(Parafovea Limits)
From 1.2 mm to
2.8 mm (Perifovea)
From FAZ Limits
(500 um) to 2.8 mm
(Perifovea Limits)
From Foveola (0 um)
to 2.8 mm
(Perifovea Limits)
Temporal Nasal Temporal Nasal Temporal Nasal Temporal Nasal
Control
group 230 ± 20 194 ± 8 194 ± 7 150 ± 10 160 ± 10 141 ± 6 165 ± 9 280 ± 40 260 ± 40
VIII.31 137.7 ± 0.5 94 ± 2 94 ± 1 87 ± 2 98 ± 7 130 ± 10 150 ± 6 230 ± 60 290 ± 50
VII.94 20 ± 20 4 ± 5 13 ± 2 40 ± 20 4 ± 8 70 ± 10 90 ± 10 230 ± 50 120 ± 50
VII.118 173 ± 5 120 ± 10 30 ± 30 30 ± 30 20 ± 20 110 ± 20 145 ± 9 140 ± 10 140 ± 20
VII.1 119 ± 2 89 ± 4 90 ± 10 40 ± 30 50 ± 10 140 ± 20 210 ± 20 240 ± 20 220 ± 30
Retinal thickness at the FAZ shows both eyes’ average for the study patients. The mean values of the control group (n = 6) correspond to
one eye of each. Only the right eye is shown to simplify data for outer and inner retina and choroid. Abbreviations: FAZ—foveal avascular
zone; RE—right eye; LE—left eye; SD—standard deviation.
Regarding the four outer retinal bands, only VIII.31 (Figure 2A) showed a slightly
preserved external limiting membrane (ELM; red arrowhead), cone ellipsoid zone (EZ;
yellow arrowhead), and the fourth band (RPEmitZ; blue arrowhead) at the foveola. As
a foveal cavitation existed, the third band (OS tips phagocytosed by the RPE, PhaZ) was
disrupted. Some hyperreflective loci could be related to the remnants of the third band
(Figure 2A, red arrows). To a lesser extent, the first, second, and fourth outer retinal bands
were relatively maintained at the foveola in VII.118 (Figure 2C, red, yellow, and blue
arrowheads, respectively). Otherwise, the first outer band was still observed in some parts
of the foveola in VII.1 (Figure 2D, red arrowheads). Some outer retinal tubulations were
observed in VII.94, VII.118, and VII.1 (Figure 2B–D, purple arrowheads).
The outer retinal layers from FAZ limits in the four members were reduced com-
pared with healthy controls (Table 2); however, differences in retinal degeneration were
found among them. Although VIII.31 still had homogeneous degeneration throughout the
retina (Figure 2, Table 2), the OCT images of VII.94 showed a more aggressive thinning
between the foveola and parafoveal limits (Figure 2B, Table 2). In VII.118 and VII.1, peri-
foveal thinning of the outer retina seemed to be more pronounced than in the parafovea
(Figure 2C,D, Table 2). The high signal transmission on OCT, observed mainly in patient
VII.94 (Figure 2C,D), may imply a greater degeneration of the RPE.
The structure and organization of the inner retina was maintained (Figure 2), though
its thickness was usually reduced compared with healthy patients (Table 2). Foveal and
parafoveal degeneration of these layers was greater in VIII.31 and VII.94 than in VII.118
and VII.1 (Table 2). Most areas of the inner retina of VII.1 exceeded the retinal thickness of
control patients. Ganglion cell layer (GCL) distribution can be observed in Figure S4.
In general, OCT images revealed a decrease in choroid thickness in all patients com-
pared with heathy ones. Specifically, VII.94 and VII.118 showed more pronounced thinning
in the nasal area (Table 2).
3.4. OCTA in PRPH2 Gene Mutation Patients
OCTA images centered on macula were analyzed, except VII.94, which was due to a
lack of eye fixation.
3.4.1. Quantitative and Qualitative Differences Found at SVP among Patients
Patient VIII.31 had the largest avascular area in SVP compared with the other patients;
however, his vessel density was greater (Table 3). In all study patients, total vessel length
and average vessel length were lower (Figure 3A–D; Table 3). Lacunarity measurements
revealed that VII.1. had a higher vascular alteration in SVP compared with other affected
family members.
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Table 3. Quantitative analysis of retinal plexuses.
Patients
SVP Parameters ICP-DCP Parameters
Avascular Area (mm2) Angio-Tool Measurements FAZ (mm2)












RE LE Mean ± SD
Control
group 0.4 ± 0.1 0.4 ± 0.2 0.370 ± 0.001 53 ± 2 530 ± 30 10 ± 10 0.022 ± 0.003 0.3 ± 0.1 0.3 ± 0.1 0.25 ± 0.01
VIII.31 0.61 0.63 0.62 ± 0.01 47 ± 3 504 ± 7 4.0 ± 0.4 0.040 ± 0.003 0.39 0.47 0.43 ± 0.06
VII.118 0.54 0.34 0.4 ± 0.1 39.4 ± 0.7 450 ± 10 1.6 ± 0.5 0.049 ± 0.001 0.42 0.32 0.37 ± 0.07
VII.1 0.57 0.58 0.575 ± 0.007 41 ± 2 430 ± 30 2.40 ± 0.04 0.057 ± 0.001 0.46 0.47 0.465 ± 0.007
One measurement was performed on the avascular area per each OCT angiography (OCTA) image. Angio-tool values corresponds to the
mean ± SD among both eyes for study patients. Mean values of the control group (n = 6) correspond to one eye of each. Abbreviations:
SVP—superficial vascular plexus; RE—right eye; LE—left eye; SD—standard deviation.
Figure 3. OCTA images of SVP centered at the macula in control and study patients. Insets at the
right side of all images show different vascular signs in high magnification. (A) Superficial vessels of
a healthy patient, showing capillary-free zone next to the large arteries (red dotted areas) and the
FAZ, which is constituted by a single-layer of capillaries. Insets display several capillary-free zones.
(B) Some slow blood flow areas (pink solid areas) and impaired perfusion areas (green dotted areas)
already observed in addition to microaneurysms (yellow arrowheads), vascular loops or capillary
bends (red arrowheads), and IRMAs (blue arrowheads) in patient VIII.31 (LE). (C) Similar signs to
image (B) were detected in VII.118 (RE). (D) Larger slow blood flow areas (pink solid areas) and
a greater number of capillary bends (red arrowheads) are shown. Capillary dropout areas (green
dotted areas), microaneurysms (yellow arrowheads), and IRMAs (blue arrowheads) were also present
in VII.1 (LE). Scale: 200 µm. Abbreviations: superficial vascular plexus, SVP; left eye, LE; right eye,
RE. Yellow squares show microaneurysms; red squares indicate capillary bends or vascular loops;
blue squares show IRMAs.
Qualitatively, VII.1 had a widespread area with blood flow reduction, whereas VIII.31
showed the smallest area affected amongst them (Figure 3B–D, pink areas). In all cases,
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these slow blood flow areas were mainly located on the temporal side, although VII.118
and VII.1 also had some vascular degeneration closer to the fovea (Figure 3C,D, pink
areas). Total degeneration of these capillaries results in capillary dropout. It seems that
capillary loss appears close to the large vessels, thus increasing the size of capillary-
free zones (Figure 3B–D, green dotted areas). Moreover, microaneurysms (Figure 3B–D,
yellow arrowheads), vascular loops or capillary bends (Figure 3B–D, red arrowheads), and
intraretinal microvascular abnormalities (IRMA) (Figure 3B–D, blue arrowheads) were
detected. Since OCTA image quality was insufficient, no difference was observed between
vascular loops and capillary bends. All these patients had at least one of these signs
in their SVP. Microaneurysms were more easily detectable in VIII.31 (Figure 3B, yellow
arrowheads). Conversely, more vascular loops or capillary bends were found in a more
degenerate vascular network in VII.1 (Figure 3D, red arrowheads). Although VII.1 and
VII.31 had different degenerative processes, the IRMAs appeared similar (Figure 3B,D, blue
arrowheads). The smallest number of these signs was detected in VII.118 (Figure 3C).
3.4.2. Differences in ICP and DCP among Choroidal Dystrophies Patients Compared
with Controls
During the degenerative process, the ICP loses its planar structure and simply allows
a connection between the SVP and DCP. Thus, ICP and DCP images are shown in a single
slab in VII.118 and VII.1 in Figure 4.
All patients showed a larger FAZ compared with controls (Table 3). The ICP of VIII.31
was quite preserved compared with a normal ICP (Figure 4A,C). The most remarkable
difference between controls and VIII.31 was the larger size of the FAZ in the patient
with the disease (Figure 4A,C; Table 3). Moreover, several vascular loops (Figure 4C, red
arrowheads) and IRMAs (Figure 4C, yellow arrowheads) were present. Impaired perfusion
or slow blood flow were easily detectable in VIII.31 and VII.118. However, OCTA image
quality made it difficult to precisely differentiate between both signs (Figure 4D,E, the
most-affected areas are indicated in blue dotted areas). Considering these signs, and
although these patients seemed to be in different stages, the total extension of impaired
vascular perfusion areas was similar among them (Figure 4D,E, blue dotted areas). Some
capillary bends or vascular loops were also detected in VIII.31 and VII.118 (Figure 4D,E,
red arrowheads) at the ICP and DCP. Most of the deep vascular plexus (ICP + DCP) in
VII.1 had already degenerated (Figure 4F, blue dotted areas). Finally, a few spider-like
structures were detected in VIII.31 and VII.118, and their size and extent were greatly
reduced (Figure 4D,E, green square) compared with the large number of these structures
present in healthy subjects (Figure 4B, some examples are marked in green). No spider-like
structures were seen in VII.1 (Figure 4F).
3.4.3. Choriocapillaris and Choroid Degeneration in CACD and ECA Patients
Since these diseases eventually involve choroid degeneration, the choriocapillaris and
choroid were studied. The granular pattern of choriocapillaris typical of the center retina
in healthy subjects (Figure 5A) was not observed in any of these patients (Figure 5C,E,G).
VIII.31 showed the most similar choriocapillaris pattern to the controls, but relatively
widespread signal voids areas were appreciable (Figure 5C, green areas). In addition,
choriocapillaris thinning allowed the observation of some medium-sized vessels of the
inner choroid (Figure 5C, red arrowheads). Larger areas of choriocapillaris dropout or
signal voids were clearly visible in both VII.118 and VII.1 (Figure 5E,G, green areas). In
them, a small central zone of choriocapillaris close to the fovea was preserved in VII.118,
whereas choriocapillaris between the fovea and optic nerve in VII.1 maintained the granular
pattern. Some medium- and large-sized choroidal vessels were detected (Figure 5E,G,
red arrowheads).
Diagnostics 2021, 11, 777 9 of 15
Figure 4. OCTA images of ICP and DCP centered at the macula in controls and patients with
choroidal dystrophies. Insets at the right side of B, C, D, and E show different vascular signs in high
magnification. (A) ICP of a healthy patient. Insets display the typical vessels with tortuosity. (B) DCP
of a control subject where spider-like (green squares) structures surrounding the fovea can be seen.
(C) ICP of patient VII.31 (LE) showing IRMAs (yellow arrowheads) and some capillary bends (red
arrowheads). (D) Capillary dropout or slow blood flow areas (blue areas) with some degenerate
spider-like structures (green squares) and capillary bends (red arrowheads), observed in the DCP
of patient VII.31 (LE). (E) ICP and DCP images of VII.118 (RE), where larger areas of impaired
vascular perfusion (blue areas) were detected in addition to some altered spider-like structures (green
square) and capillary bends (red arrowheads). (F) Single slab of ICP and DCP of VII.1 (LE) showing
widespread capillary dropout areas (blue areas). No spider-like structures were detected. Scale:
200 × 200 µm. Abbreviations: intermediate capillary plexus, ICP; deep capillary plexus, DCP; left
eye, LE; right eye, RE. Green squares show spider-like structures; red squares indicate capillary bends
or vascular loops; blue squares show IRMA.
Diagnostics 2021, 11, 777 10 of 15
Figure 5. OCTA images of choriocapillaris (CC) and choroid centered at the macula in control and
study patients. (A) Granular pattern typical of CC of a healthy patient. (B) Choroid seen with OCTA
in a normal patient. Projection artifact of large retinal vessels can be observed. (C) CC from patient
VIII.31 (LE) with attenuated areas (green areas) between the fovea and optic nerve. Red arrowheads
indicate some inner choroid vessels due to the CC thinning. (D) Some inner and outer choroid
vessels (dark vessels) can be observed in patient VIII.31′s choroid (LE). (E) The granular pattern of
the CC is mainly preserved close to the fovea of VII.118 (RE). Green areas show impaired vascular
perfusion and red arrowheads point to some choroid vessels. (F) Vascular tortuosity (red dotted
areas) of larger vessels and focal vascular dilation (orange arrowheads) were seen in patient VII.118
(RE). (G) Larger impaired vascular perfusion areas (green areas) are shown in CC of VII.1 (LE). Thus,
inner and outer choroid vessels were detected (red arrowheads). (H) Vascular tortuosity (red dotted
areas) was present in VII.1 (LE) and inner choroid vessels were easily detected. Scale: 200 × 200 µm.
Abbreviations: choriocapillaris—CC; left eye—LE; right eye—RE.
In healthy patients, the choriocapillaris and RPE are preserved, which makes visual-
ization of the choroid difficult by OCTA. Thus, little information could be obtained from
these images (Figure 5B). However, in all patients with retinal degeneration where both
layers were degenerating, it was possible to differentiate between inner and outer choroids
(dark vessels). Choriocapillaris and RPE were partly preserved in VIII.31, which made it
possible to visualize only some of the inner and outer choroid vessels (Figure 5D). OCTA
images from choroid of VII.118 and VII.1 revealed that both individuals presented vascular
tortuosity, mainly in the larger vessels (Figure 5F,H, red dotted areas), and the radial dis-
tribution pattern from the fovea of the outer choroid was observed. The choroid of these
patients also showed areas with lower vascular density (Figure 5F,H). Specifically, VII.118
had more impaired perfusion areas and fewer vessels, with most of them being narrower
compared with VII.1. In addition, focal vascular dilation was noted in VII.118 (Figure 5F,
orange arrowheads). Thus, considering these parameters, the inner choroid seemed more
preserved in VII.1 than in VII.118.
4. Discussion
Here, we describe the clinical findings over time in four members of a Spanish family
with the p.Arg195Leu mutation in the PRPH2 gene, and who were diagnosed with central
choroidal degenerations. Qualitative and quantitative analyses of OCT and OCTA im-
ages were performed to understand the retinal findings observed during the degenerative
process. Retinal disease was detected from the third decade of life in all of them, as also de-
scribed in other studies about this mutation [12,13] and other mutations in PRPH2 [6,18,19].
However, this specific mutation was confirmed only a few years after the first examination
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in three of them (VIII.31, VII.118, and VII.1), and 20 years afterwards in VII.94. Despite
the age of onset of visual problems being similar in all four, the progression of the retinal
degeneration seemed to differ. Unlike Keilhauer et al., who found a change in the CACD
phenotype with age [13], we already found a different phenotype in younger subjects of
this Spanish family with the PRPH2 gene mutation. That is, according to the acquired
OCT and OCTA images and the medical history gathered, VIII.31 and VII.94 presented
CACD, whereas VII.118 and VII.1 showed a different phenotype: extensive chorioretinal
atrophy (ECA).
This difference in phenotypes or variability in clinical signs in members of the same
family are currently difficult to explain, though some studies have already tried to provide
this explanation for other PRPH2 gene mutations [13,20]. In our study, clear clinical
differences related to VA and visual field were observed between CACD and ECA patients.
These variations can be easily explained because CACD induces higher central retinal
degeneration, affecting the maximum VA zone, whereas ECA initially affects the mid-
peripheral retina. Despite these clinical differences, findings over time showed that the
disease progression was faster when the patient had an intermediate stage and higher VA
(VIII.31 and VII.1), and stabilized when a later stage existed presenting low VA (VII.94). This
could be explained by both diseases having their degeneration peak at early–intermediate
stages, as occurs in other retinal dystrophies [21]. It is remarkable that most of them
experienced color vision problems from the age of 20. The main color defect detected later
was tritanopia, involving blue cones [13], which are located in the parafovea [22]. This
correlates with the initially aggressive degeneration in this area.
Considering the previous classification [5] and our results with OCT and OCTA
imaging, stages of the disease are defined for these four patients. Specifically, IR, OCT,
and OCTA images in CACD patients suggest VII.94 was at a later stage than VIII.31
and appeared to show an age-dependent progression. Otherwise, this age-dependent
progression did not seem to be adjusted in our ECA patients: structural tests in VII.1
showed that he presented a more advanced stage than VII.118, even though the first patient
is younger. Greater foveal sparing was observed in VII.118; thus, his VA was higher.
Classically, CACD has been defined as an atrophy of the RPE and the choriocapillaris,
where photoreceptor degeneration cause a large loss of central vision [4–6]. Choriocapil-
laris and choroid degeneration were also thought to be one of the first events occurring
during this dystrophy, along with degeneration of the RPE, since vascular alterations
were found in the choroid with fluorescein angiography and indocyanine green angiog-
raphy [23–28]. Nevertheless, considering our results with OCT and OCTA images, we
propose a redefinition of the disease, regarding CACD as a degenerative disease of the
retina where photoreceptors, mainly cones, are the first affected, causing RPE and chori-
ocapillaris degeneration. Something similar could be applied for ECA, showing a more
widespread alteration, and affecting both types of photoreceptors. Thus, both diseases
could be categorized as mainly cone dystrophies, at least when caused by the p.Arg195Leu
PRPH2 mutation.
Some correlation appears to exist between the reduction in retinal thickness in the
FAZ and the loss of VA, which could be due to a decrease in cone photoreceptors at
the ONL. In addition, foveal cavitation, a sign of cone dysfunction described in other
retinal dystrophies [7,29,30], was present in VIII.31. Additionally, foveal cavitation was
accompanied by the disruption of the third outer retinal band (PhaZ) in this patient,
indicating that OS phagocytosis by RPE was impaired [31,32]. Considering the four outer
retinal bands, OCT images revealed that the degeneration process appears similar to
other pathologies [33,34]. The finding that PRPH2 protein is present in the OS discs of
photoreceptors [8] may explain why PhaZ disappears at first and ELM is the last to be
disrupted. In these four cases, outer and inner retinal alterations did not show different
degeneration on either the nasal or temporal side compared with the controls. However,
outer retinal degeneration and vascular disturbances seemed to be more aggressive on the
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temporal side, which agrees with published studies using experimental models of other
retinal dystrophies [35–37].
In addition to retinal degeneration, vascular disturbances such as an increase in the
size of the avascular zone at the SVP or DCP are appreciable in these patients. Specifically,
the larger avascular area in the SVP in the CACD patient may be explained by his own
degeneration pattern. However, the greater size of the FAZ of VII.1 compared with CACD
might be associated with his later-stage disease and, thus, his lower VA. The density and
length of the superficial vessels in CACD and ECA patients were reduced compared with
controls, agreeing with studies of other retinal diseases [38–40]. Some studies established
a positive correlation between macular function and vessels’ length and density [38,41];
however, in ECA patients, a reduction in VA might not be associated with a lesser vascular
density if foveal sparing exists until later stages. Otherwise, a lower vessel density may
imply greater visual field loss in this mutation.
Vascular disturbances are thought to lead to decreased blood flow velocity in the
capillaries [42], which could be seen as slow blood flow areas by OCTA. Microaneurysms
appear to be more frequent at earlier stages of the disease. As they are proper signs of
vascular degeneration onset or the less severe forms [43], their presence may indicate
higher risk of progression to more severe forms of the disease, as occurs in other patholo-
gies [44]. Vascular loops or capillary bends and IRMAs, which are proper signs of vascular
disorders [42,45,46], were similarly appreciable in these patients. Nonetheless, widespread
impaired vascular perfusion areas were more numerous in later stages (VII.1), which in-
dicated a lower vascular density. All these findings show that, although there are fewer
vessels in these late stages, most have some vascular alteration proportional to earlier
stages, so the final vascular disturbance is greater. The DCP in these dystrophies is proba-
bly, and usually, the most-disturbed plexus, since it is closest to affected photoreceptors, as
has been recently described in retinitis pigmentosa [47,48]. Our results showed that DCP,
SVP, and choriocapillaris degenerated areas seems to be linked; thus, the lack of vessels is
not associated with low-quality images.
In this study, the obtained results allowed us to redefine the clinical disease, although
only four patients were analyzed. Moreover, new clinical findings were described for the
first time in OCT and OCTA for these choroidal dystrophies. Thus, this study’s findings
encourage characterizing the rest of the affected family members to facilitate a clinical
diagnosis. Despite the high quality of the acquired OCTA images, these can be affected
by small artifacts associated with poor eye fixation in this kind of patient. Furthermore,
the quantitative analysis of OCT and OCTA images was performed by external software,
which could have conditioned the results.
5. Conclusions
Considering the previous information and the clinical findings of these patients, we
reach the following conclusions: First, the outer nuclear layer thickness and the presence
of four outer retinal bands at the foveola and the FAZ size are the signs that most affect
VA. The parafoveal and perifoveal degeneration of the outer and inner retina or other
vascular alterations seem not to be as decisive in VA. Second, this PRPH2 mutation firstly
causes alterations in the photoreceptor–RPE complex, followed by the degeneration of
the inner retina, retinal plexuses, and choriocapillaris. Third, this study confirms that
vascular alterations are signs of these choroidal dystrophies. Forth, despite all family
members having the same mutation, there was wide variability in terms of clinical findings,
progression of the disease, and visual acuity among patients. Fifth, OCT and OCTA images
can help to more appropriately distinguish the clinical disease (CACD from ECA) by
offering more detailed information than fundus images. Finally, all the affected members
coming from a common ancestor allowed us to locate the disease in a specific area, with a
large number of affected people, and, thus, enabled the development of clinical trials.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/diagnostics11050777/s1, Figure S1: Location of macular components in OCT images;
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Figure S2: Infrared images of right (upper) and left (down) eyes of control (A,B) and patients with
PRPH2 gene mutation (C-I); Figure S3: Three-dimensional reconstruction from a dense OCT scan
of some study patients associated to p.Arg195Leu mutation; Figure S4: Volume scan of the GCL
thickness map (right) at 1, 2, and 3 circle diameters from the foveola. References [32,42,45,46,49,50]
are cited in the Supplementary Materials.
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